BNP Paribas Financial Markets
NNVC icon

BNP Paribas Financial Markets’s NanoViricides NNVC Stock Holding History

BNP Paribas Financial Markets’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-49
Closed -$2.21K – 3594
2015
Q1 		$2.21K Buy
+49
New +$2.61K ﹤0.01% 3461
2014
Q4 		– Sell
-121
Closed -$7.25K – 2788
2014
Q3 		$7.25K Buy
+121
New +$9.5K ﹤0.01% 3729

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Colony Group
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BNP Paribas Financial Markets's NNVC Position: Q2 2015 in Review

BNP Paribas Financial Markets sold out of NanoViricides (NNVC) in Q2 2015, closing a stake of 49 shares — an estimated $2.21K sold.

BNP Paribas Financial Markets first reported a position in NNVC in Q3 2014 and held it in 2 quarters. The position peaked at $7.25K in Q3 2014. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2015.

  • BNP Paribas Financial Markets reported no remaining NanoViricides position as of Q2 2015 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 49 NanoViricides shares in Q2 2015, an estimated $2.21K.
  • BNP Paribas Financial Markets first reported a position in NanoViricides in Q3 2014 and held it in 2 quarters.
  • BNP Paribas Financial Markets's NanoViricides position peaked at $7.25K in Q3 2014.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2015.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.